Movement disorders : official journal of the Movement Disorder Society · 2026
Gray Matter Volume Loss in Parkinson's Disease Psychosis and Cannabinoid Receptor Gene Expression in the Brain.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Pisani Sara, Váša František, Velayudhan Latha, Bhattacharyya Sagnik
Аннотация
BACKGROUND: Serotonergic and dopaminergic pathways are implicated in Parkinson's disease psychosis (PDP), but preliminary evidence also implicates the endocannabinoid system (ECS).
OBJECTIVES: We examined the association of gray matter volume loss in PDP patients with brain expression of the genes coding for CB1 (cannabinoid type 1) and CB2 cannabinoid receptors obtained from an independent sample.
METHODS: Hedges' g effect sizes indexing gray matter volume loss were extracted from a previous meta-analytic comparison of PDP and PD without psychosis. The relationship of cortical and subcortical CB1 and CB2 gene expression in 6 healthy individuals extracted from the Allen Human Brain Atlas with meta-analytic estimates of PDP-related volume loss was examined correcting for spatial autocorrelation.
RESULTS: There was a significant association between gray matter volume loss in PDP and CB1 (r = 0.337, t(76) = 3.122, P < 0.001) but not CB2 (P = 0.132, corrected) receptor brain expression.
CONCLUSIONS: This finding underscores the importance of investigating the role of the ECS in PD. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
OBJECTIVES: We examined the association of gray matter volume loss in PDP patients with brain expression of the genes coding for CB1 (cannabinoid type 1) and CB2 cannabinoid receptors obtained from an independent sample.
METHODS: Hedges' g effect sizes indexing gray matter volume loss were extracted from a previous meta-analytic comparison of PDP and PD without psychosis. The relationship of cortical and subcortical CB1 and CB2 gene expression in 6 healthy individuals extracted from the Allen Human Brain Atlas with meta-analytic estimates of PDP-related volume loss was examined correcting for spatial autocorrelation.
RESULTS: There was a significant association between gray matter volume loss in PDP and CB1 (r = 0.337, t(76) = 3.122, P < 0.001) but not CB2 (P = 0.132, corrected) receptor brain expression.
CONCLUSIONS: This finding underscores the importance of investigating the role of the ECS in PD. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.